$51.300
-2.755 (-5.37%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de DRUG por análisis de gráficos similares
Alphio's DRUG stock price prediction model matches the current Bright Minds Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $50.89 (-0.79%). The 1-week path is $51.79 (+0.95%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Bright Minds Biosciences Inc?
Currently, Bright Minds Biosciences Inc (DRUG) is not a good buy due to its recent performance and financial metrics. The stock is trading at $51.30, down 38.53% year-to-date, and the RSI is at 44.59, indicating a lack of bullish momentum. Although analysts have set a price target of $220, the significant losses in net income over the last quarters raise concerns about its immediate viability.
DRUG cerró en $51.30 el Friday, tras bajar -5.37%
Bright Minds Biosciences Inc (DRUG) last closed at $51.3, losing -5.37%. These facts feed the 1-day and 1-week DRUG price prediction above.
Factores de la previsión
Los factores de la previsión de Bright Minds Biosciences Inc (DRUG) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de DRUG, ordenadas por similitud.
Análisis de estacionalidad de DRUG
Historically the probability of a positive October return for DRUG is 63.79%. November offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de DRUG
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $28.65 | $31.00 | $35.50 | -39.56% |
| Nov 2026 | $24.76 | $28.06 | $30.05 | -45.30% |
| Dec 2026 | $25.45 | $27.20 | $27.32 | -46.99% |
En 2026, se proyecta que Bright Minds Biosciences Inc (DRUG) oscile entre $24.76 y $35.50.
Previsión mensual de Bright Minds Biosciences Inc para 2026
En Oct de 2026, se proyecta que Bright Minds Biosciences Inc promedie $31.00, con un mínimo de $28.65 y un máximo de $35.50.
En Nov de 2026, se proyecta que Bright Minds Biosciences Inc promedie $28.06, con un mínimo de $24.76 y un máximo de $30.05.
En Dec de 2026, se proyecta que Bright Minds Biosciences Inc promedie $27.20, con un mínimo de $25.45 y un máximo de $27.32.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.